Inventor

ABERG A K GUNNAR

US60 patents

⚠️ This page may combine multiple inventors who share the name “ABERG A K GUNNAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ABERG A K GUNNAR

BRIDGE PHARMA INC

Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use

Optically active isomers of ketotifen and therapeutically active metabolites thereof

Methods for treating urinary incontinence and other disorders using trospium

Non-arrhythmogenic metabolite of oxybutynin

Treating urinary incontinence with (R)-desethyloxybutynin and (R)-oxybutynin

Dermal anesthetic agents

Benzocycloheptathiophene compounds

Optically active isomers of ketotifen and therapeutically active metabolites thereof

Use of RR/SR-ractopamine

Methods of accelerating muscle growth and improving feed efficiency in animals by using optically pure eutomers of adrenergic beta-2 receptor agonists, and food supplements containing the same

Methods of treatment of non-histaminic pruritus

Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders

Methods of treatment of histamine H-4 receptor-related pruritus

Medicinal treatment of dermal diseases in dogs

Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals

Non-sedating diphenhydramine metabolites

Ocular formulations of norketotifen

Smooth muscle spasmolytic agents, compositions and methods of use thereof

Methods for treating urinary incontinence in patients suffering from memory disorders

Smooth muscle spasmolytic agents

Methods of treatment of asthma and COPD

Methods of treatment of asthma and COPD

Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals

SEPRACOR INC

Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Compositions of optically pure (−) norcisapride

Methods for treating central nervous system disorders and other disorders using optically pure (-) norcisapride

Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride

Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients

Methods for treating disorders using descarboethoxyloratadine

Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole

Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients

Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients

Methods for treating allergic disorders using norastemizole

Methods and compositions for treating infection using optically pure (S)-lomefloxacin

Compositions for treating infection using optically pure (S)-lomefloxacin

Compositions of optically pure (-) norcisapride and another therapeutic agent

Methods for treating infection using optically pure (S)-lomefloxacin

Methods for the treatment of allergic rhinitis

Compositions of descarboethoxyloratadine

Methods for treating urticaria using descarboethoxyloratadine

Methods for treating disorders using norastemizole in combination with other active ingredients

SQUIBB & SONS INC

Method for preventing onset of restenosis after angioplasty employing an ace inhibitor

Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug

Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator

Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromboxane A2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation

Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor

Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor

ABERG A K GUNNAR

Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen

Treating xerophthalmia with norketotifen

Use of RR/SR-ractopamine